<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//Springer-Verlag//DTD A++ V2.4//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName A++V2.4.dtd?><?SourceDTD.Version 2.4?><?ConverterInfo.XSLTName springer2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Microb Cell Fact</journal-id><journal-id journal-id-type="iso-abbrev">Microb. Cell Fact</journal-id><journal-title-group><journal-title>Microbial Cell Factories</journal-title></journal-title-group><issn pub-type="epub">1475-2859</issn><publisher><publisher-name>BioMed Central</publisher-name><publisher-loc>London</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">6112128</article-id><article-id pub-id-type="publisher-id">978</article-id><article-id pub-id-type="doi">10.1186/s12934-018-0978-8</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research</subject></subj-group></article-categories><title-group><article-title>Discovery and characterization of the tubercidin biosynthetic pathway from <italic>Streptomyces tubercidicus</italic> NBRC 13090</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Liu</surname><given-names>Yan</given-names></name><address><email>liuyan_hb@163.com</email></address><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Gong</surname><given-names>Rong</given-names></name><address><email>gongrong@whu.edu.cn</email></address><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Liu</surname><given-names>Xiaoqin</given-names></name><address><email>liuxiaoqin@whu.edu.cn</email></address><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Zhang</surname><given-names>Peichao</given-names></name><address><email>zhangpeichao@stu.ouc.edu.cn</email></address><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Zhang</surname><given-names>Qi</given-names></name><address><email>151847114@qq.com</email></address><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Cai</surname><given-names>You-Sheng</given-names></name><address><email>cysh2002@163.com</email></address><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Deng</surname><given-names>Zixin</given-names></name><address><email>zxdeng@sjtu.edu.cn</email></address><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Winkler</surname><given-names>Margit</given-names></name><address><email>margit.winkler@tugraz.at</email></address><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Wu</surname><given-names>Jianguo</given-names></name><address><email>jwu@whu.edu.cn</email></address><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-2557-8960</contrib-id><name><surname>Chen</surname><given-names>Wenqing</given-names></name><address><email>wqchen@whu.edu.cn</email></address><xref ref-type="aff" rid="Aff2">2</xref></contrib><aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 2331 6153</institution-id><institution-id institution-id-type="GRID">grid.49470.3e</institution-id><institution>State Key Laboratory of Virology, and College of Life Sciences, </institution><institution>Wuhan University, </institution></institution-wrap>Wuhan, 430072 China </aff><aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 2331 6153</institution-id><institution-id institution-id-type="GRID">grid.49470.3e</institution-id><institution>Key Laboratory of Combinatorial Biosynthesis and Drug Discovery, Ministry of Education, and School of Pharmaceutical Sciences, </institution><institution>Wuhan University, </institution></institution-wrap>Wuhan, 430071 China </aff><aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 0591 4434</institution-id><institution-id institution-id-type="GRID">grid.432147.7</institution-id><institution>Austrian Centre of Industrial Biotechnology, </institution></institution-wrap>Petersgasse 14, 8010 Graz, Austria </aff></contrib-group><pub-date pub-type="epub"><day>28</day><month>8</month><year>2018</year></pub-date><pub-date pub-type="pmc-release"><day>28</day><month>8</month><year>2018</year></pub-date><pub-date pub-type="collection"><year>2018</year></pub-date><volume>17</volume><elocation-id>131</elocation-id><history><date date-type="received"><day>2</day><month>7</month><year>2018</year></date><date date-type="accepted"><day>14</day><month>8</month><year>2018</year></date></history><permissions><copyright-statement>&#x000a9; The Author(s) 2018</copyright-statement><license license-type="OpenAccess"><license-p><bold>Open Access</bold>This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p></license></permissions><abstract id="Abs1"><sec><title>Background</title><p id="Par1">Tubercidin (TBN), an adenosine analog with potent antimycobacteria and antitumor bioactivities, highlights an intriguing structure, in which a 7-deazapurine core is linked to the ribose moiety by an <italic>N</italic>-glycosidic bond. However, the molecular logic underlying the biosynthesis of this antibiotic has remained poorly understood.</p></sec><sec><title>Results</title><p id="Par2">Here, we report the discovery and characterization of the TBN biosynthetic pathway from <italic>Streptomyces tubercidicus</italic> NBRC 13090 via reconstitution of its production in a heterologous host. We demonstrated that TubE specifically utilizes phosphoribosylpyrophosphate and 7-carboxy-7-deazaguanine for the precise construction of the deazapurine nucleoside scaffold. Moreover, we provided biochemical evidence that TubD functions as an NADPH-dependent reductase, catalyzing irreversible reductive deamination. Finally, we verified that TubG acts as a Nudix hydrolase, preferring Co<sup>2+</sup> for the maintenance of maximal activity, and is responsible for the tailoring hydrolysis step leading to TBN.</p></sec><sec><title>Conclusions</title><p id="Par3">These findings lay a foundation for the rational generation of TBN analogs through synthetic biology strategy, and also open the way for the target-directed search of TBN-related antibiotics.</p></sec><sec><title>Electronic supplementary material</title><p>The online version of this article (10.1186/s12934-018-0978-8) contains supplementary material, which is available to authorized users.</p></sec></abstract><kwd-group xml:lang="en"><title>Keywords</title><kwd>Biosynthesis</kwd><kwd>Tubercidin</kwd><kwd>7-deazapurine</kwd><kwd>Phosphoribosylpyrophosphate</kwd><kwd>NADPH-dependent reductase</kwd><kwd>Nudix hydrolase</kwd><kwd>Synthetic biology</kwd></kwd-group><funding-group><award-group><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001809</institution-id><institution>National Natural Science Foundation of China</institution></institution-wrap></funding-source><award-id>31770041</award-id><principal-award-recipient><name><surname>Chen</surname><given-names>Wenqing</given-names></name></principal-award-recipient></award-group></funding-group><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#x000a9; The Author(s) 2018</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1"><title>Background</title><p id="Par4">Pyrrolopyrimidine (also known as 7-deazapurine) containing compounds have been discovered to be widely distributed in nature as microbial secondary metabolites (SMs) and also as hypermodified base (queuosine) in RNA [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR2">2</xref>]. Usually, this family of SMs shows diverse biological functions, ranging from cofactors (involved in the biosynthesis of tetracycline antibiotics) as well as DNA repair to antibiotics with herbicidal, antibacterial, antiviral, antifungal, antitumor, and antineoplastic activities [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR2">2</xref>]. Previously, toyocamycin/sangivamycin (produced by <italic>Streptomyces rimosus</italic> ATCC 14673) and tubercidin (TBN, produced by <italic>Streptomyces tubercidicus</italic> NBRC 13090) served as prototypes for the deazapurines (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>a) [<xref ref-type="bibr" rid="CR2">2</xref>&#x02013;<xref ref-type="bibr" rid="CR4">4</xref>]. Since their discovery, a series of structurally-related antibiotics has been continuously isolated from terrestrial and marine sources with guidance of bioactivity assays (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>a) [<xref ref-type="bibr" rid="CR2">2</xref>].<fig id="Fig1"><label>Fig.&#x000a0;1</label><caption><p>Structures of TBN and related antibiotics and the confirmed biosynthetic pathway to PreQ<sub>0</sub>. <bold>a</bold> Chemical structures of TBN and related purine nucleoside antibiotics. TBN is produced by <italic>S. tubercidicus</italic> NBRC 13090; 5&#x02032;-sulfamoyl TBN is produced by <italic>S. mirabilis;</italic> cadeguomycin is produced by <italic>S. hygroscopicus</italic>; sangivamycin/toyocamycin is produced by <italic>S. rimosus</italic> ATCC 14673; kanagawamicin is produced by <italic>Actinoplanes kanagawaensis</italic>; echiguanine A is produced by <italic>Streptomyces</italic> sp. MI698-50F1; Ara-A (arabinofuranosyladenine) is produced by <italic>S. antibioticus</italic> NRRL 3238. <bold>b</bold> The confirmed biosynthetic pathway leading to PreQ<sub>0</sub>. A four-enzyme cascade for the synthesis of PreQ<sub>0</sub> is identified in both queuosine and sangivamycin/toyocamycin biosynthetic pathways. GCH I, GTP cyclohydrolase I (ToyD); QueD/ToyB, 6-carboxy-5,6,7,8-tetrahydropterin (CPH<sub>4</sub>) synthase; H<sub>2</sub>NTP, 7, 8-dihydroneopterin-3&#x02032;-triphosphate; QueE/ToyC, 7-carboxy-7-deazaguanine (CDG) synthase; QueC/ToyM, 7-cyano-7-deazaguanine (PreQ<sub>0</sub>) synthetase</p></caption><graphic xlink:href="12934_2018_978_Fig1_HTML" id="MO1"/></fig>
</p><p id="Par5">Tubercidin is susceptible to phosphorylation by adenosine kinase to mono-, di-, and tri-phosphorylated forms accounting for its structural resemblance to adenosine [<xref ref-type="bibr" rid="CR5">5</xref>, <xref ref-type="bibr" rid="CR6">6</xref>]. Accordingly, it is capable of acting as a powerful inhibitor of RNA and DNA polymerase, and shows a relatively-broad spectrum of bioactivities [<xref ref-type="bibr" rid="CR2">2</xref>]. TBN is bioactive against <italic>Candida albicans</italic>, <italic>Mycobacterium tuberculosis</italic>, and <italic>Streptococcus faecalis</italic>, however, it exhibits no inhibition of other Gram positive bacteria and fungi [<xref ref-type="bibr" rid="CR2">2</xref>, <xref ref-type="bibr" rid="CR5">5</xref>]. In addition, TBN shows antiviral and antitumor activities [<xref ref-type="bibr" rid="CR5">5</xref>], and more interestingly, it can also kill trypanosomes by targeting glycolysis, especially by inhibition of phosphoglycerate kinase [<xref ref-type="bibr" rid="CR7">7</xref>].</p><p id="Par6">TBN features an unusual deazapurine core, in which N-7 is substituted for C-7 (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>a) [<xref ref-type="bibr" rid="CR4">4</xref>]. Previous metabolic labeling experiments indicated that the deazapurine core is derived from a purine precursor, likely GTP, and C-1&#x02032;, 2&#x02032;, and 3&#x02032; of ribose are utilized to construct the pyrrole ring with elimination of C-8 in GTP [<xref ref-type="bibr" rid="CR8">8</xref>, <xref ref-type="bibr" rid="CR9">9</xref>]. Subsequently, the enzymatic logic for the construction of deazapurine core has been deciphered by independent studies, which were focused on the identification of the biosynthetic pathway of queuosine and toyocamycin/sangivamycin (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>b) [<xref ref-type="bibr" rid="CR2">2</xref>, <xref ref-type="bibr" rid="CR10">10</xref>]. A four-enzyme cascade has been demonstrated to be responsible for the biosynthetic steps leading to PreQ<sub>0</sub> (7-cyano-7-deazaguanine) (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>b). Among them, GTP cyclohydrolase I (GCH I, ToyD) catalyzes the first step from GTP to H<sub>2</sub>NTP (7, 8-dihydroneopterin-3&#x02032;-triphosphate) with opening the ribose ring, followed by a series of Amadori rearrangement and subsequent recyclization. The intermediate H<sub>2</sub>NTP is then sequentially recognized by CPH<sub>4</sub> (6-carboxy-5, 6, 7, 8-tetrahydropterin) synthase (QueD/ToyB) and CDG synthase (QueE/ToyC) [<xref ref-type="bibr" rid="CR2">2</xref>, <xref ref-type="bibr" rid="CR10">10</xref>]. The enzymatic mechanism of QueE/ToyC, a member of the radical <italic>S</italic>-adenosyl-<sc>l</sc>-methionine (SAM) protein, has been elucidated by elegant studies of the Bandarian group. This enzyme catalyzes a key SAM- and Mg<sup>2+</sup>-dependent radical-mediated ring contraction step [<xref ref-type="bibr" rid="CR11">11</xref>, <xref ref-type="bibr" rid="CR12">12</xref>], which is common to the biosynthetic pathways of all deazapurine-containing compounds. More recently, QueC/ToyM has been verified as an amide synthetase, as well as a nitrile synthetase, which could accept both the acid and amide forms of CDG enabling sequential amidation and dehydration to the nitrile [<xref ref-type="bibr" rid="CR13">13</xref>, <xref ref-type="bibr" rid="CR14">14</xref>].</p><p id="Par7">Although the distinguished activities and unusual structure of TBN are well known, nature&#x02019;s strategy for the building of this molecule has as yet remained poorly understood. In the present study, we have identified the TBN biosynthetic gene cluster from <italic>S. tubercidicus</italic> NBRC 13090 (<italic>S. tubercidicus</italic> hereafter) by engineered production of TBN in a heterologous host, and have further elucidated that TBN biosynthesis involves a PRPP-dependent assembly logic associated with tailoring reduction and phosphohydrolysis steps. Our deciphering of the TBN biosynthetic pathway provides a solid basis for the further combinatorial biosynthesis of this group of nucleoside antibiotics towards improved features, and opens the way for the target-directed genome mining of novel TBN-related antibiotics from the available microbial genome reservoirs.</p></sec><sec id="Sec2"><title>Results</title><sec id="Sec3"><title>Identification of the TBN biosynthetic gene cluster</title><p id="Par8">To identify the gene cluster for TBN biosynthesis, the genome of <italic>S. tubercidicus</italic> was sequenced by an Illumina Hiseq method, rendering appr. 7.88-Mb of non-redundant bases after assembly of clean reads (Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Table S1). The genomic data was then annotated by Glimmer 3.02 software, affording 7263 open reading frames (ORFs) (Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Table S1). TBN features the deazapurine core, which is also existed in toyocamycin, sangivamycin, and other related antibiotics; we therefore deduced that the initial enzymatic steps for the building of the core of them follow an identical logic. We accordingly utilized ToyD (GTP cyclohydrolase I) and ToyB (CPH<sub>4</sub> synthase) as the enzyme probes to conduct BlastP analysis against the genome of <italic>S. tubercidicus</italic>. As expected, a candidate gene cluster (<italic>tub</italic>) encoding enzymes involving TubC (64% identity to ToyD) and TubA (65% identity to ToyB) was identified from the genome (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2</xref>a, Table&#x000a0;<xref rid="Tab1" ref-type="table">1</xref>). Further looking through the surrounding region resulted in the identification of the genes coding for a radical SAM enzyme (TubB) and a GMP reductase (TubD) (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2</xref>a, Table&#x000a0;<xref rid="Tab1" ref-type="table">1</xref>). These results suggest that the <italic>tub</italic> gene cluster is very likely responsible for the biosynthesis of TBN.<fig id="Fig2"><label>Fig.&#x000a0;2</label><caption><p>Genetic organization and validation of the gene cluster (<italic>tub</italic>) for TBN biosynthesis. <bold>a</bold> Genetic organization of the <italic>tub</italic> gene cluster. <bold>b</bold> LC&#x02013;MS analysis of the target metabolite produced by the recombinants of <italic>S. coelicolor</italic> M1154. TBN Std, the authentic standard of TBN; WT, the metabolites of the wild type TBN producer <italic>S. tubercidicus</italic>; M1154/12G4, the metabolites of <italic>S. coelicolor</italic> M1154 derivative harboring the cosmid 12G4; M1154/pJTU2463b, the metabolites of <italic>S. coelicolor</italic> M1154 derivative harboring the plasmid pJTU2463b as negative control</p></caption><graphic xlink:href="12934_2018_978_Fig2_HTML" id="MO2"/></fig>
<table-wrap id="Tab1"><label>Table&#x000a0;1</label><caption><p>Deduced functions of the open reading frames in the <italic>tub</italic> gene cluster</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Protein</th><th align="left">aa</th><th align="left">Proposed function</th><th align="left">Homolog, Origin</th><th align="left">Identity, similarity (%)</th><th align="left">Accession no.</th></tr></thead><tbody><tr><td align="left">Orf-1</td><td char="." align="char">58</td><td align="left">(2Fe-2S)-binding protein</td><td align="left">AWI43_15300, <italic>Streptomyces</italic> sp. WAC04657</td><td align="left">78, 83</td><td align="left">KYG55615.1</td></tr><tr><td align="left">TubA</td><td char="." align="char">125</td><td align="left">CPH<sub>4</sub> synthase</td><td align="left">ToyB, <italic>Streptomyces rimosus</italic> ATCC 14673</td><td align="left">65, 79</td><td align="left">ACF06634.1</td></tr><tr><td align="left">TubB</td><td char="." align="char">139</td><td align="left">Radical SAM family protein</td><td align="left">SPAR_33961, <italic>Streptomyces sparsogenes</italic> DSM 40356</td><td align="left">71, 79</td><td align="left">OMI34937.1</td></tr><tr><td align="left">TubC</td><td char="." align="char">199</td><td align="left">GTP cyclohydrolase I (GCH I)</td><td align="left">ToyD, <italic>Streptomyces rimosus</italic> ATCC 14673</td><td align="left">64, 75</td><td align="left">ACF06635.1</td></tr><tr><td align="left">TubD</td><td char="." align="char">385</td><td align="left">GMP reductase</td><td align="left">ToyE, <italic>Streptomyces rimosus</italic> ATCC 14673</td><td align="left">61, 75</td><td align="left">ACF06636.1</td></tr><tr><td align="left">TubE</td><td char="." align="char">194</td><td align="left">Phosphoribosylpyrophosphate transferase</td><td align="left">ToyH, <italic>Streptomyces rimosus</italic> ATCC 14673</td><td align="left">39, 53</td><td align="left">ACF06639.1</td></tr><tr><td align="left">TubF</td><td char="." align="char">422</td><td align="left">UbiD family decarboxylase</td><td align="left">ASE41_09730, <italic>Streptomyces</italic> sp. Root264</td><td align="left">90, 93</td><td align="left">KRD23282.1</td></tr><tr><td align="left">TubG</td><td char="." align="char">168</td><td align="left">Nudix hydrolase</td><td align="left">ASE41_09725, <italic>Streptomyces</italic> sp. Root264</td><td align="left">96, 96</td><td align="left">KRD23281.1</td></tr><tr><td align="left">TubH</td><td char="." align="char">314</td><td align="left">Carbohydrate kinase family protein</td><td align="left">ASE41_09720, <italic>Streptomyces</italic> sp. Root264</td><td align="left">82, 86</td><td align="left">KRD23280.1</td></tr><tr><td align="left">TubI</td><td char="." align="char">374</td><td align="left">MFS transporter</td><td align="left">ASE41_09715, <italic>Streptomyces</italic> sp. Root264</td><td align="left">83, 88</td><td align="left">KRD23279.1</td></tr><tr><td align="left">Orf1</td><td char="." align="char">68</td><td align="left">Hypothetical protein</td><td align="left">ASE41_09630, <italic>Streptomyces</italic> sp. Root264</td><td align="left">41, 60</td><td align="left">KRD23264.1</td></tr></tbody></table></table-wrap>
</p></sec><sec id="Sec4"><title>Engineered production of TBN in the heterologous host <italic>S. coelicolor</italic> M1154</title><p id="Par9">To correlate the <italic>tub</italic> gene cluster to TBN production, a cosmid 12G4 (with appr. 30.0-kb insertion DNA, Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Table S2) harboring the TBN gene cluster was screened from the pJTU2463b-derived genomic library of <italic>S. tubercidicus</italic> (Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Table S2), and then it was introduced into the heterologous host <italic>S. coelicolor</italic> M1154 [<xref ref-type="bibr" rid="CR15">15</xref>] via conjugation. The validated conjugants were then fermented for further metabolite analysis, and LC&#x02013;MS analysis indicated that the sample (M1154/12G4) is capable of producing the distinctive [M+H]<sup>+</sup> ion of TBN at <italic>m/z</italic> 267.1080 (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2</xref>a). In addition, MS/MS analysis showed that the main fragments were generated at 134.8841, 248.9537, 231.1378, and so forth, fully consistent with those of the TBN authentic standard (Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Figure S1). These combined data unambiguously demonstrate that the cosmid 12G4 confers the heterologous host <italic>S. coelicolor</italic> M1154 with the capability of TBN production.</p></sec><sec id="Sec5"><title>In silico analysis of the TBN biosynthetic gene cluster</title><p id="Par10">In silico analysis showed that the TBN gene cluster spans appr. 8.0-kb continuous chromosomal region, and consists of 9 genes (<italic>tubA</italic>-<italic>I</italic>) (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2</xref>a, Table&#x000a0;<xref rid="Tab1" ref-type="table">1</xref>). Genes <italic>tubCBA</italic> are proposed to be responsible for the initial biosynthetic steps to CDG. The gene <italic>tubC</italic> codes for GTP cyclohydrolase I which shows 64% identity to ToyD of toyocamycin biosynthesis, and the product of <italic>tubB</italic> (radical SAM enzyme) exhibits 71% identity to SPAR_33961 of <italic>S. sparsogenes</italic> DSM 40356. <italic>tubA</italic> encodes CPH<sub>4</sub> synthase that indicates significant similarity (65% identity) to ToyB in toyocamycin biosynthetic pathway. <italic>tubD</italic> encodes a GMP reductase (61% identity to ToyE) that is proposed to be responsible for IMP (Inosine-5&#x02032;-monophosphate) biosynthesis, whereas TubE has 39% identity to ToyH, an enzyme hypothetically responsible for the assembly step during toyocamycin biosynthesis. TubF exhibits high similarity (90% identity to ASE41_09730 from <italic>Streptomyces</italic> sp. Root264) to UbiD family decaboxylases, which bear a recently identified cofactor prFMN (prenylated-FMN) [<xref ref-type="bibr" rid="CR16">16</xref>&#x02013;<xref ref-type="bibr" rid="CR19">19</xref>], but the roles of most UbiD family decaboxylases are functionally unassigned. TubG is annotated as a Nudix hydrolase, and this family of enzymes usually plays &#x0201c;house-cleaning&#x0201d; role to sanitize nucleotide pool in primary metabolism [<xref ref-type="bibr" rid="CR20">20</xref>]. <italic>tubHI</italic> individually code for carbohydrate kinase family protein (82% identity to ASE41_09720) and MFS (Major facilitator superfamily) transporter.</p></sec><sec id="Sec6"><title>TubE functions as a CDG-PRPP phosphoribosyltransferase</title><p id="Par11">BlastP analysis indicates that <italic>tubE</italic> encodes a purine phosphoribosylpyrophosphate transferase (Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Figure S2), which likely governs the assembly step during TBN biosynthesis. To determine if TubE fulfills such enzymatic role, we overexpressed and purified the protein to near homogeneity from <italic>E. coli</italic> (Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Figure S3A), and tested its activity in vitro first, using deazaguanine and PRPP as substrates, and LC&#x02013;MS results indicated that the TubE reaction could not generate the expected product (Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Figure S3B, C), suggesting that this enzyme does not recognize deazaguanine as a substrate. As a result, we ponder whether the assembly step is prior to decarboxylation during TBN biosynthesis (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>b), namely, CDG is the prime substrate of TubE. We then re-examined TubE activity using this compound as substrate, and HPLC analysis showed that the TubE reaction is capable of generating a new peak at RT&#x02009;=&#x02009;24.7&#x000a0;min, which is absent in the negative control (Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3</xref>b). Further LC&#x02013;MS analysis indicated that the target peak (RT&#x02009;=&#x02009;24.7&#x000a0;min) could produce a characteristic [M+H]<sup>+</sup> ion at <italic>m/z</italic> 407.0591 (Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3</xref>b) with main fragment ions at 177.9070, 194.9660, 294.0352, and 389.0653, well matched to the theoretical fragmentation pattern of compound <bold>1</bold> (Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Figure S3D). To finally clarify the chemical identity of the product (<bold>1</bold>) formed by TubE, it was purified and analyzed by nuclear magnetic resonance (NMR). The results showed that <sup>1</sup>H, <sup>13</sup>C, and 2D NMR signals of the compound are highly consistent with those of <bold>1</bold>, confirming that the TubE-catalyzed product is <bold>1</bold> (Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Figures S4, S5). Taken together, all of the data demonstrate that TubE functions as a CDG-specific phosphoribosyltransferase.<fig id="Fig3"><label>Fig.&#x000a0;3</label><caption><p>Biochemical characterization of TubE as a CDG-PRPP transferase. <bold>a</bold> Schematic of the TubE-catalyzed reaction in the presence of PRPP and CDG. <bold>b</bold> HPLC analysis of the TubE reaction. TubE reaction, HPLC profile of the TubE reaction using PRPP and CDG as substrates; Negative control, HPLC profile of the reaction using PRPP and CDG as substrates but without TubE added. Compound <bold>X</bold> shows [M+H]<sup>+</sup> ion at <italic>m/z</italic> 327.0923, with main fragment ions at 177.9827, 194.9009, 292.0454, and 309.9970, which are fully consistent with the theoretical fragmentation pattern of dephosphorylated <bold>1</bold></p></caption><graphic xlink:href="12934_2018_978_Fig3_HTML" id="MO3"/></fig>
</p></sec><sec id="Sec7"><title>Biochemical characterization of TubD as an NADPH-dependent reductase</title><p id="Par12">In silico analysis exhibited that TubD bears an IMP dehydrogenase/GMP reductase domain (Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Figure S6), implicating that TubD should play a similar role in TBN biosynthesis (presumably converting compound <bold>2</bold> to <bold>3</bold>) (Fig.&#x000a0;<xref rid="Fig4" ref-type="fig">4</xref>a). To see if TubD is capable of performing this function, it was expressed and purified from <italic>E. coli</italic> (Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Figure S7A). We then tested its activity in vitro using GMP, an analog of <bold>2</bold>, as a substrate (Fig.&#x000a0;<xref rid="Fig4" ref-type="fig">4</xref>a). LC&#x02013;MS analysis showed the target IMP [M+H]<sup>+</sup> ion at <italic>m/z</italic> 349.0540 in the TubD reaction, while it was absent in the negative control (Fig.&#x000a0;<xref rid="Fig4" ref-type="fig">4</xref>b). In addition, MS/MS analysis indicated that the predominant fragment ions were generated at 118.8544, 136.8826, 233.0000, and 331.0666, fully consistent with those of the IMP authentic standard (Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Figure S7B, C). Subsequently, we tested cofactor specificity for TubD activity, and LC&#x02013;MS analysis showed that TubD reaction with NADH as cofactor could not give rise to the target IMP [M+H]<sup>+</sup> ion, suggesting that this cofactor could not replace NADPH to supply reducing equivalents for the TubD reaction (Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Figure S7D). Moreover, we also tested the factors that potentially affect TubD activity, and found that the metal ion K<sup>+</sup> plays a pivotal role for TubD activity (Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Figure S7D). These combined data suggest that TubD is an NADPH-dependent reductase catalyzing reductive deamination of compound <bold>2</bold> to <bold>3</bold> in TBN biosynthesis.<fig id="Fig4"><label>Fig.&#x000a0;4</label><caption><p>In vitro characterization of TubD as an NADPH-dependent reductase. <bold>a</bold> Schematic of the TubD-catalyzed reaction in the presence of the redox cofactor NADPH. <bold>b</bold> LC&#x02013;MC analysis of the TubD reaction. Std, EIC analysis of the authentic standards of IMP and GMP; +NADPH, EIC analysis of the TubD reaction with NADPH as redox cofactor; +NADH, EIC analysis of the TubD reaction with NADH as redox cofactor; N.C, EIC analysis of the reaction with NADPH and substrate added but lacking the enzyme TubD</p></caption><graphic xlink:href="12934_2018_978_Fig4_HTML" id="MO4"/></fig>
</p></sec><sec id="Sec8"><title>Biochemical characterization of TubG as a tailoring Nudix hydrolase</title><p id="Par13">Bioinformatic analysis showed that TubG possesses a highly conserved 23-residue (GX5EX7REUXEEXGU) Nudix motif (Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Figure S8) [<xref ref-type="bibr" rid="CR21">21</xref>], which normally functions as a metal binding and catalytic site, accordingly, this protein is predicted to be a Nudix hydrolase for the final tailoring step during TBN biosynthesis. To determine if TubG executes the delineated functional role, it was overexpressed and purified from <italic>E. coli</italic> to near homogeneity (Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Figure S9A). We then tested TubG activity using AMP (compound <bold>5</bold> analog) as an alternative substrate (Fig.&#x000a0;<xref rid="Fig5" ref-type="fig">5</xref>a), and HPLC analysis indicated that the TubG catalyzed reaction produced the expected adenosine peak but not in the TubG-negative control (Fig.&#x000a0;<xref rid="Fig5" ref-type="fig">5</xref>b). Further LC&#x02013;MS results indicated that the peak could give rise to the target [M+H]<sup>+</sup> ion at <italic>m/z</italic> 268.1034, whose fragmentation pattern is fully in accordance with that of the adenosine standard (Fig.&#x000a0;<xref rid="Fig5" ref-type="fig">5</xref>b, Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Figure S9B, C). In addition, we evaluated the divalent cations affecting enzymatic activity of TubG. Of all divalent cations (involving Mg<sup>2+</sup>, Ni<sup>2+</sup>, Mn<sup>2+</sup>, Co<sup>2+</sup>, Ca<sup>2+</sup>, Fe<sup>2+</sup>, Cu<sup>2+</sup>, and Zn<sup>2+</sup>) selected, we found that Co<sup>2+</sup> is capable of maintaining the maximal enzymatic activity for TubG (Fig.&#x000a0;<xref rid="Fig5" ref-type="fig">5</xref>c). All of this suggests that TubG is an atypical Nudix hydrolase using Co<sup>2+</sup> as the most preferred divalent cation.<fig id="Fig5"><label>Fig.&#x000a0;5</label><caption><p>In vitro characterization of TubG as a Nudix hydrolase responsible for the final hydrolysis step. <bold>a</bold> Schematic of the TubG-catalyzed reaction using the analog of <bold>5</bold>, AMP, as substrate. <bold>b</bold> HPLC traces of the TubG reaction. Std, the authentic standards of AMP and adenosine; TubG, HPLC traces of the TubG reaction with AMP as substrate; N.C, EIC analysis of the reaction with AMP as substrate added but without TubG added. <bold>c</bold> Relative activity of TubG with AMP as substrate and different divalent cations as metallic cofactor</p></caption><graphic xlink:href="12934_2018_978_Fig5_HTML" id="MO5"/></fig>
</p></sec></sec><sec id="Sec9"><title>Discussion</title><p id="Par14">Previous labeling and biosynthetic studies revealed that GTP is the direct substrate for the biosynthesis of the 7-deazapurine core in toyocamycin/sangivamycin, and a three-enzyme cascade, including GCH I (GTP cyclohydrolase I), CPH<sub>4</sub> synthase (6-carboxyl-5,6,7,8-tetrahydropterin synthase), and CDG synthase (7-carboxy-7-deazaguanine synthase), accomplishes the biosynthesis of the 7-deazapurine core [<xref ref-type="bibr" rid="CR10">10</xref>]. In the present study, this mechanism is also shown to be suitable for the building of TBN scaffold. Three enzymes, TubC (GCH I), TubA (CPH<sub>4</sub> synthase), and TubB (CDG synthase), are found in the biosynthetic pathway to TBN. TubC is proposed to govern the initial step, catalyzing GTP transformation to H<sub>2</sub>NTP, which is subsequently converted to CPH<sub>4</sub> by TubA (Fig.&#x000a0;<xref rid="Fig6" ref-type="fig">6</xref>). TubB (CDG synthase) is proposed to employ a radical and Mg<sup>2+</sup> dependent strategy to realize the radical-mediated ring contraction step in the course of CDG biosynthesis (Fig.&#x000a0;<xref rid="Fig6" ref-type="fig">6</xref>).<fig id="Fig6"><label>Fig.&#x000a0;6</label><caption><p>Proposed biosynthetic pathway to TBN. PurA, adenylosuccinate synthetase; PurB, adenylosuccinate lyase</p></caption><graphic xlink:href="12934_2018_978_Fig6_HTML" id="MO6"/></fig>
</p><p id="Par15">Earlier bioinformatic analysis speculated that the 7-deazapurine core (7-cyano-7-deazaguanine/PreQ<sub>0</sub>) is biosynthesized preceding its assembly [<xref ref-type="bibr" rid="CR2">2</xref>, <xref ref-type="bibr" rid="CR10">10</xref>]. In the present study, it seems to be logic and feasible in the TBN pathway. Two enzymes, TubE (PRPP transferase), and TubF (UbiD family decarboxylase), are demonstrated to be involved in the described enzymatic steps (Fig.&#x000a0;<xref rid="Fig6" ref-type="fig">6</xref>). We initially deduced that CDG is likely to undergo decarboxylation prior to its condensation with PRPP for the accomplishment of assembly step, while TubE is not able to accept 7-deazaguanosine as the substrate. We therefore propose that CDG is first converted by TubE to form compound <bold>1</bold>, which is then decarboxylated to compound <bold>2</bold> by TubF, an unusual decarboxylase likely using prenylated-FMN (prFMN) as cofactor (Fig.&#x000a0;<xref rid="Fig6" ref-type="fig">6</xref>).</p><p id="Par16">For the tailoring steps during TBN biosynthesis, TubD (NADPH-dependent reductase) and TubG (Nudix hydrolase), which were characterized in the present study using natural substrate analogs, are established to participate in the enzymatic reactions, compound <bold>2</bold> (GMP analog) is converted to <bold>3</bold> (IMP analog). We could imagine that these two enzymes definitely show the preference to the natural substrates, however, it is also commonly acceptable to explore the catalytic mechanisms of certain enzymes with substrate analogs [<xref ref-type="bibr" rid="CR22">22</xref>]. Indeed, enzymes are often rationally evolved to accept artificial substrate analogs for industrial biocatalysis purposes [<xref ref-type="bibr" rid="CR22">22</xref>]. It is very interesting to ask why the enzymes for the sequential transformation of <bold>3</bold> to <bold>4</bold>, and to <bold>5</bold> are missing in the TBN pathway. Compound <bold>3</bold> is structurally similar to IMP; as a result, it is reasonable to propose that the missing two enzymes, adenylosuccinate synthetase (PurA), and adenylosuccinate lyase (PurB), could be certainly &#x0201c;borrowed&#x0201d; from the primary purine metabolic pathway (Fig.&#x000a0;<xref rid="Fig6" ref-type="fig">6</xref>). As for compound <bold>5,</bold> it is confirmed to be hydrolyzed by TubG with removal of a phosphate for the accomplishment of TBN biosynthesis (Fig.&#x000a0;<xref rid="Fig6" ref-type="fig">6</xref>).</p><p id="Par17">There are two other enzymes, TubH (kinase), and TubI (MFS transporter), also present in the TBN pathway. It is more reasonable to propose that TubI is responsible for transporting TBN out of the cell once synthesized. With respect to TubH, the assignment of its functional role in TBN biosynthesis is highly challenging. Previous studies showed that TBN is toxic to <italic>M. tuberculosis,</italic> and accordingly, it is acceptable to hypothesize that this compound is also potentially toxic to the host cell. Microbes have developed several intricate strategies for the self-resistance of its secondary metabolites during the long-term evolution, undoubtedly, targeted modification (e.g. phosphorylation) of the target antibiotic should be a more effective and convenient tactic, and a similar case for antibiotic self-resistance by host cell has been previously reported in capuramycin biosynthesis [<xref ref-type="bibr" rid="CR23">23</xref>]. From this perspective, we tentatively propose that TubH is likely to play a self-resistance role by phosphorylating TBN to relieve its potential toxicity to host cells, and related research is now underway.</p><p id="Par18">Notably, the advent of rapid and affordable next-generation DNA sequencing has revolutionized and accelerated the traditional programs for the discovery of chemical diversities [<xref ref-type="bibr" rid="CR24">24</xref>]. Therefore, TBN could be used as a promising template for the target-directed genome mining of related antibiotics, and we have already been rewarded with uncovering several potential TBN-related antibiotics pathways from the currently-available reservoir of the microbial genomes (Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Figure S10). As a consequence, it would be of great interest in the future to hunt for novel 7-deazapurine-containing antibiotics by targeted genome mining approach.</p></sec><sec id="Sec10"><title>Conclusion</title><p id="Par19">In summary, we report the discovery and functional analysis of the TBN biosynthetic pathway. We have determined that TBN biosynthesis employs a PRPP dependent strategy for the deazanucleoside scaffold assembly, and we have also provided the biochemical evidence that TubD and TubG are involved in the tailoring reduction and phosphohydrolysis steps. We anticipate that the deciphering of the biosynthetic puzzle of TBN will open the way for future combinatorial biosynthesis of this family of antibiotics for the rational generation of novel analogs with enhanced features.</p></sec><sec id="Sec11"><title>Methods</title><sec id="Sec12"><title>Materials and general methods</title><p id="Par20">Strains, plasmids used in this study are described in Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Table S2, and PCR primers are listed in Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Table S3. All of the enzymes (except for the DNA polymerase) were the products of New England Biolabs. The TBN standard was purchased from Medchem Express (MCE). Chemicals were purchased from Sigma-Aldrich, Thermo Scientific, J&#x00026;K Scientific, or Sinopharm unless otherwise indicated. Standard protocols were employed to manipulate <italic>E. coli</italic> or <italic>Streptomyces</italic> according to those of Green et al. [<xref ref-type="bibr" rid="CR25">25</xref>] or Kieser et al. [<xref ref-type="bibr" rid="CR26">26</xref>].</p></sec><sec id="Sec13"><title>Sequencing analysis of the genome of <italic>S. tubercidicus</italic></title><p id="Par21">Genomic DNA of <italic>S. tubercidicus</italic> was isolated on the basis of the standard protocol [<xref ref-type="bibr" rid="CR26">26</xref>], and the genome sequencing was performed using the Illumina Hiseq4000 sequencing system, and the assembled sequence data was then annotated using the Glimmer 3.02 software. The online programs FramePlot 4.0beta (<ext-link ext-link-type="uri" xlink:href="http://nocardia.nih.go.jp/fp4/">http://nocardia.nih.go.jp/fp4/</ext-link>) and 2ndFind (<ext-link ext-link-type="uri" xlink:href="http://biosyn.nih.go.jp/2ndfind/">http://biosyn.nih.go.jp/2ndfind/</ext-link>) were utilized for the accurate analysis of the TBN gene cluster.</p></sec><sec id="Sec14"><title>Accession numbers</title><p id="Par22">The DNA sequence of the <italic>tub</italic> gene cluster is deposited in the GenBank database under accession number MG706975.</p></sec><sec id="Sec15"><title>Genomic library construction and screening for <italic>S. tubercidicus</italic></title><p id="Par23">For the construction of pJTU2463b-derived genomic library for <italic>S. tubercidicus,</italic> standard method was adopted, using the EPI300-T1R as suitable host cells, and a narrow-down PCR screening strategy [<xref ref-type="bibr" rid="CR27">27</xref>] with primers TubidF/R were employed to screen the positive cosmid 12G4 from the genomic library.</p></sec><sec id="Sec16"><title>Fermentation of related <italic>Streptomyces</italic> strains for TBN production</title><p id="Par24">For production of TBN, <italic>Streptomyces</italic> strains were inoculated in TSB medium and cultivated for 2&#x000a0;days, after that, the cultures (2%, V/V) were transferred to fermentation medium (including 20&#x000a0;g glucose, 30&#x000a0;g soluble starch, 10&#x000a0;g corn steep liquor, 10&#x000a0;g soybean meal, 5&#x000a0;g peptone, 2&#x000a0;g NaCl, 5&#x000a0;g CaCO<sub>3</sub>, pH 7.0) and fermented (180&#x000a0;r/min, 28&#x000a0;&#x000b0;C) for 5&#x000a0;days. Subsequently, the fermentation beer was processed (adding oxalic acid till pH 3.0) for LC&#x02013;MS analysis.</p></sec><sec id="Sec17"><title>Overexpression and purification of TubE, TubD, and TubG in <italic>E. coli</italic> Rosetta (DE3)/pLysS</title><p id="Par25">For overexpression of these proteins, their structural genes were amplified by KOD-plus DNA polymerase (TOYOBO) using related primers listed in Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Table S3. Then the <italic>Nde</italic>I&#x02013;<italic>Eco</italic>RI engineered DNA fragments were individually cloned into the counterpart sites of pET28a. After confirmation by sequencing, the related constructs were subsequently transformed into <italic>E. coli</italic> Rosetta (DE3)/pLysS cells according to the standard protocols [<xref ref-type="bibr" rid="CR25">25</xref>]. Expression and purification for the His6-tagged proteins were conducted according to the method by Wu et al. [<xref ref-type="bibr" rid="CR28">28</xref>].</p></sec><sec id="Sec18"><title>Enzymatic assays of TubE</title><p id="Par26">For TubE activity, the reaction mixture (100&#x000a0;mM PBS buffer, pH 7.5; 1&#x000a0;mM CDG; 2&#x000a0;mM PRPP; 5&#x000a0;mM MgCl<sub>2</sub>; 1&#x000a0;mM DTT and 20&#x000a0;&#x003bc;g protein) was incubated at 30&#x000a0;&#x000b0;C for 8&#x000a0;h, and then terminated by the immediate addition of an equivalent volume methanol. After centrifugation to remove protein, the supernatant was filtrated by 0.22&#x000a0;&#x003bc;m filter. HPLC (Shimadzu LC-20A) analysis was performed on a reverse phase C18 column (Inertsil ODS-3, 4.6&#x02009;&#x000d7;&#x02009;250&#x000a0;mm, 5&#x000a0;&#x000b5;m) with the elution gradient of 5%&#x02013;30% methanol:0.15% TFA over 35&#x000a0;min at a flow rate of 0.5&#x000a0;ml/min, and the elution was monitored at UV295&#x000a0;nm by a DAD detector.</p></sec><sec id="Sec19"><title>Enzymatic assays of TubD</title><p id="Par27">For TubD activity, the reaction containing 100&#x000a0;mM Tris&#x02013;HCl buffer (pH 7.5), 1&#x000a0;mM GMP, 1&#x000a0;mM NADPH/NADH, 1&#x000a0;mM DTT, 50&#x000a0;mM KCl, 2&#x000a0;mM EDTA, and 20&#x000a0;&#x003bc;g protein, incubated at 30&#x000a0;&#x000b0;C for 4&#x000a0;h, then the supernatant was analyzed by LC&#x02013;HRMS with the elution gradient of 5%&#x02013;25% methanol:0.15% TFA over 20&#x000a0;min at a flow rate of 0.4&#x000a0;ml/min.</p></sec><sec id="Sec20"><title>Enzymatic assays of TubG</title><p id="Par28">The complete TubG reaction including 100&#x000a0;mM Tris&#x02013;HCl buffer (pH 7.0), 1&#x000a0;mM AMP, 100&#x000a0;mM KCl, 5&#x000a0;mM divalent ion (Mg<sup>2+</sup>, Ni<sup>2+</sup>, Mn<sup>2+</sup>, Co<sup>2+</sup>, Ca<sup>2+</sup>, Fe<sup>2+</sup>, Cu<sup>2+</sup>, and Zn<sup>2+</sup>), and 20&#x000a0;&#x003bc;g protein, was incubated at 30&#x000a0;&#x000b0;C for 4&#x000a0;h. The protein in reaction was removed by adding an equal volume of methanol, then the supernatant was analyzed by HPLC (Shimadzu LC-20A) equipped with C-18 reversed-phase column (Inertsil ODS-3, 4.6&#x02009;&#x000d7;&#x02009;250&#x000a0;mm, 5&#x000a0;&#x000b5;m) with 5%&#x02013;30% methanol:0.15% TFA over 15&#x000a0;min at a flow rate of 0.4&#x000a0;ml/min, the condition (30% methanol:0.15% TFA) was maintained for another 10&#x000a0;min.</p></sec><sec id="Sec21"><title>The conditions for LC&#x02013;MS analysis</title><p id="Par29">LC&#x02013;MS analysis was carried out on a Thermo Fisher Scientific ESI-LTQ Orbitrap (Scientific Inc.) equipped with a C-18 reversed-phase column (Inertsil ODS-3, 4.6&#x02009;&#x000d7;&#x02009;250&#x000a0;mm, 5&#x000a0;&#x000b5;m) in positive mode with an elution gradient of 5%&#x02013;30% Methanol:0.15% TFA over 30&#x000a0;min at 0.5&#x000a0;ml/min, and the parameters for the LC&#x02013;MS analysis are as follows: Dry gas at 275&#x000a0;&#x000b0;C, 10&#x000a0;l/ml, and nebulizer pressure of 30 psi.</p></sec></sec><sec sec-type="supplementary-material"><title>Additional file</title><sec id="Sec22"><p>
<supplementary-material content-type="local-data" id="MOESM1"><media xlink:href="12934_2018_978_MOESM1_ESM.pdf"><caption><p><bold>Additional file 1: Figure S1.</bold> LC-MS analysis of the target metabolite produced by <italic>S. coelicolor</italic> M1154/12G4. <bold>Figure S2.</bold> Bioinformatic analysis of the phosphoribosyltransferase TubE with its homologs. <bold>Figure S3.</bold> Biochemical characterization of TubE reaction. <bold>Figure S4.</bold>
<sup>1</sup>H and <sup>13</sup>C NMR analysis of the compound <bold>1</bold>. <bold>Figure S5.</bold>
<sup>1</sup>H-<sup>1</sup>H cosy, HMBC, and HSQC spectrums of the compound <bold>1. Figure S6.</bold> Bioinformatic analysis of the GMP reductase TubD with its homologs. <bold>Figure S7.</bold> Biochemical characterization of TubD-catalyzed reaction. <bold>Figure S8.</bold> Bioinformatics analysis of the Nudix superfamily hydrolase TubG. <bold>Figure S9.</bold> Biochemical analysis of TubG and its reaction. <bold>Figure S10.</bold> Target-directed genome mining of the gene clusters for the potential TBN-related antibiotics. <bold>Table S1.</bold> Parameters for the genome sequencing and assembly of <italic>S. tubercidicus</italic>. <bold>Table S2.</bold> Strains, plasmids and cosmids used in this study. <bold>Table S3.</bold> PCR primers used in this study.</p></caption></media></supplementary-material>
</p></sec></sec></body><back><ack><title>Authors&#x02019; contributions</title><p>YL, RG, XL, and PZ carried out experiments, QZ and YSC analyzed the primary data. YL, JW, and WC wrote the manuscript. WC and JW conceived the project and supervised the research. MW and ZD help with the critical reading of the manuscript. All authors read and approved the final manuscript.</p><sec id="FPar1"><title>Acknowledgements</title><p id="Par30">We are very grateful to Prof. Guo-Qiang Chen (Tsinghua University) and Prof. Lili Zhang (Tarim University) for kindly providing us with the strains containing the potential TBN biosynthetic gene cluster.</p></sec><sec id="FPar2"><title>Competing interests</title><p id="Par31">The authors declare that they have no competing interests.</p></sec><sec id="FPar3"><title>Availability of data and materials</title><p id="Par32">The dataset(s) supporting the conclusions of this article is (are) included within the article [and its additional file(s)].</p></sec><sec id="FPar4"><title>Consent for publication</title><p id="Par33">Not applicable.</p></sec><sec id="FPar5"><title>Ethics approval and consent to participate</title><p id="Par34">Not applicable.</p></sec><sec id="FPar6"><title>Funding</title><p id="Par35">This work was supported by grants of the National Natural Science Foundation of China (31770041).</p></sec><sec id="FPar7"><title>Publisher&#x02019;s Note</title><p id="Par36">Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></sec></ack><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Isono</surname><given-names>K</given-names></name></person-group><article-title>Nucleoside antibiotics: structure, biological activity, and biosynthesis</article-title><source>J Antibiot (Tokyo)</source><year>1988</year><volume>41</volume><fpage>1711</fpage><lpage>1739</lpage><pub-id pub-id-type="doi">10.7164/antibiotics.41.1711</pub-id><pub-id pub-id-type="pmid">3061990</pub-id></element-citation></ref><ref id="CR2"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McCarty</surname><given-names>RM</given-names></name><name><surname>Bandarian</surname><given-names>V</given-names></name></person-group><article-title>Biosynthesis of pyrrolopyrimidines</article-title><source>Bioorg Chem</source><year>2012</year><volume>43</volume><fpage>15</fpage><lpage>25</lpage><pub-id pub-id-type="doi">10.1016/j.bioorg.2012.01.001</pub-id><pub-id pub-id-type="pmid">22382038</pub-id></element-citation></ref><ref id="CR3"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Anzai</surname><given-names>K</given-names></name><name><surname>Nakamura</surname><given-names>G</given-names></name><name><surname>Suzuki</surname><given-names>S</given-names></name></person-group><article-title>A new antibiotic, tubercidin</article-title><source>J Antibiot (Tokyo)</source><year>1957</year><volume>10</volume><fpage>201</fpage><lpage>204</lpage><pub-id pub-id-type="pmid">13513512</pub-id></element-citation></ref><ref id="CR4"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mizuno</surname><given-names>Y</given-names></name><name><surname>Ikehara</surname><given-names>M</given-names></name><name><surname>Watanabe</surname><given-names>K</given-names></name><name><surname>Suzaki</surname><given-names>S</given-names></name></person-group><article-title>Structural elucidation of tubercidin</article-title><source>Chem Pharm Bull (Tokyo)</source><year>1963</year><volume>11</volume><fpage>1091</fpage><lpage>1094</lpage><pub-id pub-id-type="doi">10.1248/cpb.11.1091</pub-id><pub-id pub-id-type="pmid">5888561</pub-id></element-citation></ref><ref id="CR5"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bloch</surname><given-names>A</given-names></name><name><surname>Mihich</surname><given-names>E</given-names></name><name><surname>Leonard</surname><given-names>RJ</given-names></name><name><surname>Nichol</surname><given-names>CA</given-names></name></person-group><article-title>Studies on the biologic activity and mode of action of 7-deazainosine</article-title><source>Cancer Res</source><year>1969</year><volume>29</volume><fpage>110</fpage><lpage>115</lpage><pub-id pub-id-type="pmid">4974300</pub-id></element-citation></ref><ref id="CR6"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lindberg</surname><given-names>B</given-names></name><name><surname>Klenow</surname><given-names>H</given-names></name><name><surname>Hansen</surname><given-names>K</given-names></name></person-group><article-title>Some properties of partially purified mammalian adenosine kinase</article-title><source>J Biol Chem</source><year>1967</year><volume>242</volume><fpage>350</fpage><lpage>356</lpage><pub-id pub-id-type="pmid">4290214</pub-id></element-citation></ref><ref id="CR7"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Drew</surname><given-names>ME</given-names></name><name><surname>Morris</surname><given-names>JC</given-names></name><name><surname>Wang</surname><given-names>Z</given-names></name><name><surname>Wells</surname><given-names>L</given-names></name><name><surname>Sanchez</surname><given-names>M</given-names></name><name><surname>Landfear</surname><given-names>SM</given-names></name><name><surname>Englund</surname><given-names>PT</given-names></name></person-group><article-title>The adenosine analog tubercidin inhibits glycolysis in <italic>Trypanosoma brucei</italic> as revealed by an RNA interference library</article-title><source>J Biol Chem</source><year>2003</year><volume>278</volume><fpage>46596</fpage><lpage>46600</lpage><pub-id pub-id-type="doi">10.1074/jbc.M309320200</pub-id><pub-id pub-id-type="pmid">12972414</pub-id></element-citation></ref><ref id="CR8"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smulson</surname><given-names>ME</given-names></name><name><surname>Suhadolnik</surname><given-names>RJ</given-names></name></person-group><article-title>The biosynthesis of the 7-deazaadenine ribonucleoside, tubercidin, by <italic>Streptomyces tubercidicus</italic></article-title><source>J Biol Chem</source><year>1967</year><volume>242</volume><fpage>2872</fpage><lpage>2876</lpage><pub-id pub-id-type="pmid">6027250</pub-id></element-citation></ref><ref id="CR9"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yoo</surname><given-names>JC</given-names></name><name><surname>Han</surname><given-names>JM</given-names></name><name><surname>Ko</surname><given-names>OH</given-names></name><name><surname>Bang</surname><given-names>HJ</given-names></name></person-group><article-title>Purification and characterization of GTP cyclohydrolase I from <italic>Streptomyces tubercidicus</italic>, a producer of tubercidin</article-title><source>Arch Pharm Res</source><year>1998</year><volume>21</volume><fpage>692</fpage><lpage>697</lpage><pub-id pub-id-type="doi">10.1007/BF02976759</pub-id><pub-id pub-id-type="pmid">9868539</pub-id></element-citation></ref><ref id="CR10"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McCarty</surname><given-names>RM</given-names></name><name><surname>Bandarian</surname><given-names>V</given-names></name></person-group><article-title>Deciphering deazapurine biosynthesis: pathway for pyrrolopyrimidine nucleosides toyocamycin and sangivamycin</article-title><source>Chem Biol</source><year>2008</year><volume>15</volume><fpage>790</fpage><lpage>798</lpage><pub-id pub-id-type="doi">10.1016/j.chembiol.2008.07.012</pub-id><pub-id pub-id-type="pmid">18721750</pub-id></element-citation></ref><ref id="CR11"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dowling</surname><given-names>DP</given-names></name><name><surname>Bruender</surname><given-names>NA</given-names></name><name><surname>Young</surname><given-names>AP</given-names></name><name><surname>McCarty</surname><given-names>RM</given-names></name><name><surname>Bandarian</surname><given-names>V</given-names></name><name><surname>Drennan</surname><given-names>CL</given-names></name></person-group><article-title>Radical SAM enzyme QueE defines a new minimal core fold and metal-dependent mechanism</article-title><source>Nat Chem Biol</source><year>2014</year><volume>10</volume><fpage>106</fpage><lpage>112</lpage><pub-id pub-id-type="doi">10.1038/nchembio.1426</pub-id><pub-id pub-id-type="pmid">24362703</pub-id></element-citation></ref><ref id="CR12"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bandarian</surname><given-names>V</given-names></name><name><surname>Drennan</surname><given-names>CL</given-names></name></person-group><article-title>Radical-mediated ring contraction in the biosynthesis of 7-deazapurines</article-title><source>Curr Opin Struct Biol</source><year>2015</year><volume>35</volume><fpage>116</fpage><lpage>124</lpage><pub-id pub-id-type="doi">10.1016/j.sbi.2015.11.005</pub-id><pub-id pub-id-type="pmid">26643180</pub-id></element-citation></ref><ref id="CR13"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nelp</surname><given-names>MT</given-names></name><name><surname>Bandarian</surname><given-names>V</given-names></name></person-group><article-title>A single enzyme transforms a carboxylic acid into a nitrile through an amide intermediate</article-title><source>Angew Chem Int Ed Engl</source><year>2015</year><volume>54</volume><fpage>10627</fpage><lpage>10629</lpage><pub-id pub-id-type="doi">10.1002/anie.201504505</pub-id><pub-id pub-id-type="pmid">26228534</pub-id></element-citation></ref><ref id="CR14"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Winkler</surname><given-names>M</given-names></name><name><surname>Dokulil</surname><given-names>K</given-names></name><name><surname>Weber</surname><given-names>H</given-names></name><name><surname>Pavkov-Keller</surname><given-names>T</given-names></name><name><surname>Wilding</surname><given-names>B</given-names></name></person-group><article-title>The nitrile-forming enzyme 7-cyano-7-deazaguanine synthase from <italic>Geobacillus kaustophilus</italic>: a reverse nitrilase?</article-title><source>ChemBioChem</source><year>2015</year><volume>16</volume><fpage>2373</fpage><lpage>2378</lpage><pub-id pub-id-type="doi">10.1002/cbic.201500335</pub-id><pub-id pub-id-type="pmid">26391327</pub-id></element-citation></ref><ref id="CR15"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gomez-Escribano</surname><given-names>JP</given-names></name><name><surname>Bibb</surname><given-names>MJ</given-names></name></person-group><article-title>Engineering <italic>Streptomyces coelicolor</italic> for heterologous expression of secondary metabolite gene clusters</article-title><source>Microb Biotechnol</source><year>2011</year><volume>4</volume><fpage>207</fpage><lpage>215</lpage><pub-id pub-id-type="doi">10.1111/j.1751-7915.2010.00219.x</pub-id><pub-id pub-id-type="pmid">21342466</pub-id></element-citation></ref><ref id="CR16"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marshall</surname><given-names>SA</given-names></name><name><surname>Payne</surname><given-names>KAP</given-names></name><name><surname>Leys</surname><given-names>D</given-names></name></person-group><article-title>The UbiX-UbiD system: the biosynthesis and use of prenylated flavin (prFMN)</article-title><source>Arch Biochem Biophys</source><year>2017</year><volume>632</volume><fpage>209</fpage><lpage>221</lpage><pub-id pub-id-type="doi">10.1016/j.abb.2017.07.014</pub-id><pub-id pub-id-type="pmid">28754323</pub-id></element-citation></ref><ref id="CR17"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>White</surname><given-names>MD</given-names></name><name><surname>Payne</surname><given-names>KA</given-names></name><name><surname>Fisher</surname><given-names>K</given-names></name><name><surname>Marshall</surname><given-names>SA</given-names></name><name><surname>Parker</surname><given-names>D</given-names></name><name><surname>Rattray</surname><given-names>NJ</given-names></name><name><surname>Trivedi</surname><given-names>DK</given-names></name><name><surname>Goodacre</surname><given-names>R</given-names></name><name><surname>Rigby</surname><given-names>SE</given-names></name><name><surname>Scrutton</surname><given-names>NS</given-names></name><etal/></person-group><article-title>UbiX is a flavin prenyltransferase required for bacterial ubiquinone biosynthesis</article-title><source>Nature</source><year>2015</year><volume>522</volume><fpage>502</fpage><lpage>506</lpage><pub-id pub-id-type="doi">10.1038/nature14559</pub-id><pub-id pub-id-type="pmid">26083743</pub-id></element-citation></ref><ref id="CR18"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Payne</surname><given-names>KA</given-names></name><name><surname>White</surname><given-names>MD</given-names></name><name><surname>Fisher</surname><given-names>K</given-names></name><name><surname>Khara</surname><given-names>B</given-names></name><name><surname>Bailey</surname><given-names>SS</given-names></name><name><surname>Parker</surname><given-names>D</given-names></name><name><surname>Rattray</surname><given-names>NJ</given-names></name><name><surname>Trivedi</surname><given-names>DK</given-names></name><name><surname>Goodacre</surname><given-names>R</given-names></name><name><surname>Beveridge</surname><given-names>R</given-names></name><etal/></person-group><article-title>New cofactor supports alpha, beta-unsaturated acid decarboxylation via 1,3-dipolar cycloaddition</article-title><source>Nature</source><year>2015</year><volume>522</volume><fpage>497</fpage><lpage>501</lpage><pub-id pub-id-type="doi">10.1038/nature14560</pub-id><pub-id pub-id-type="pmid">26083754</pub-id></element-citation></ref><ref id="CR19"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>F</given-names></name><name><surname>Ferguson</surname><given-names>KL</given-names></name><name><surname>Boyer</surname><given-names>DR</given-names></name><name><surname>Lin</surname><given-names>XN</given-names></name><name><surname>Marsh</surname><given-names>EN</given-names></name></person-group><article-title>Isofunctional enzymes PAD1 and UbiX catalyze formation of a novel cofactor required by ferulic acid decarboxylase and 4-hydroxy-3-polyprenylbenzoic acid decarboxylase</article-title><source>ACS Chem Biol</source><year>2015</year><volume>10</volume><fpage>1137</fpage><lpage>1144</lpage><pub-id pub-id-type="doi">10.1021/cb5008103</pub-id><pub-id pub-id-type="pmid">25647642</pub-id></element-citation></ref><ref id="CR20"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bessman</surname><given-names>MJ</given-names></name><name><surname>Frick</surname><given-names>DN</given-names></name><name><surname>O&#x02019;Handley</surname><given-names>SF</given-names></name></person-group><article-title>The MutT proteins or &#x0201c;Nudix&#x0201d; hydrolases, a family of versatile, widely distributed, &#x0201c;housecleaning&#x0201d; enzymes</article-title><source>J Biol Chem</source><year>1996</year><volume>271</volume><fpage>25059</fpage><lpage>25062</lpage><pub-id pub-id-type="doi">10.1074/jbc.271.41.25059</pub-id><pub-id pub-id-type="pmid">8810257</pub-id></element-citation></ref><ref id="CR21"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gao</surname><given-names>Y</given-names></name><name><surname>Xu</surname><given-names>G</given-names></name><name><surname>Wu</surname><given-names>P</given-names></name><name><surname>Liu</surname><given-names>J</given-names></name><name><surname>Cai</surname><given-names>YS</given-names></name><name><surname>Deng</surname><given-names>Z</given-names></name><name><surname>Chen</surname><given-names>W</given-names></name></person-group><article-title>Biosynthesis of 2&#x02032;-chloropentostatin and 2&#x02032;-amino-2&#x02032;-deoxyadenosine highlights a single gene cluster responsible for two independent pathways in <italic>Actinomadura</italic> sp. Strain ATCC 39365</article-title><source>Appl Environ Microbiol</source><year>2017</year></element-citation></ref><ref id="CR22"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Winkler</surname><given-names>M</given-names></name></person-group><article-title>Carboxylic acid reductase enzymes (CARs)</article-title><source>Curr Opin Chem Biol</source><year>2018</year><volume>43</volume><fpage>23</fpage><lpage>29</lpage><pub-id pub-id-type="doi">10.1016/j.cbpa.2017.10.006</pub-id><pub-id pub-id-type="pmid">29127833</pub-id></element-citation></ref><ref id="CR23"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>Z</given-names></name><name><surname>Funabashi</surname><given-names>M</given-names></name><name><surname>Nonaka</surname><given-names>K</given-names></name><name><surname>Hosobuchi</surname><given-names>M</given-names></name><name><surname>Shibata</surname><given-names>T</given-names></name><name><surname>Pahari</surname><given-names>P</given-names></name><name><surname>Van Lanen</surname><given-names>SG</given-names></name></person-group><article-title>Functional and kinetic analysis of the phosphotransferase CapP conferring selective self-resistance to capuramycin antibiotics</article-title><source>J Biol Chem</source><year>2010</year><volume>285</volume><fpage>12899</fpage><lpage>12905</lpage><pub-id pub-id-type="doi">10.1074/jbc.M110.104141</pub-id><pub-id pub-id-type="pmid">20202936</pub-id></element-citation></ref><ref id="CR24"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bachmann</surname><given-names>BO</given-names></name><name><surname>Van Lanen</surname><given-names>SG</given-names></name><name><surname>Baltz</surname><given-names>RH</given-names></name></person-group><article-title>Microbial genome mining for accelerated natural products discovery: is a renaissance in the making?</article-title><source>J Ind Microbiol Biotechnol</source><year>2014</year><volume>41</volume><fpage>175</fpage><lpage>184</lpage><pub-id pub-id-type="doi">10.1007/s10295-013-1389-9</pub-id><pub-id pub-id-type="pmid">24342967</pub-id></element-citation></ref><ref id="CR25"><label>25.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Green</surname><given-names>MR</given-names></name><name><surname>Sambrook</surname><given-names>J</given-names></name></person-group><source>Molecular cloning: a laboratory manual</source><year>2002</year><edition>3</edition><publisher-loc>New York</publisher-loc><publisher-name>Cold Spring Harbor Laboratory Press</publisher-name></element-citation></ref><ref id="CR26"><label>26.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Kieser</surname><given-names>T</given-names></name><name><surname>Bibb</surname><given-names>MJ</given-names></name><name><surname>Chater</surname><given-names>KF</given-names></name><name><surname>Butter</surname><given-names>MJ</given-names></name><name><surname>Hopwood</surname><given-names>DA</given-names></name></person-group><source>Practical streptomyces genetics</source><year>2000</year><edition>2</edition><publisher-loc>Norwich</publisher-loc><publisher-name>John Innes Foundation</publisher-name></element-citation></ref><ref id="CR27"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cheng</surname><given-names>L</given-names></name><name><surname>Chen</surname><given-names>W</given-names></name><name><surname>Zhai</surname><given-names>L</given-names></name><name><surname>Xu</surname><given-names>D</given-names></name><name><surname>Huang</surname><given-names>T</given-names></name><name><surname>Lin</surname><given-names>S</given-names></name><name><surname>Zhou</surname><given-names>X</given-names></name><name><surname>Deng</surname><given-names>Z</given-names></name></person-group><article-title>Identification of the gene cluster involved in muraymycin biosynthesis from <italic>Streptomyces</italic> sp. NRRL 30471</article-title><source>Mol BioSyst</source><year>2011</year><volume>7</volume><fpage>920</fpage><lpage>927</lpage><pub-id pub-id-type="doi">10.1039/C0MB00237B</pub-id><pub-id pub-id-type="pmid">21180767</pub-id></element-citation></ref><ref id="CR28"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>P</given-names></name><name><surname>Wan</surname><given-names>D</given-names></name><name><surname>Xu</surname><given-names>G</given-names></name><name><surname>Wang</surname><given-names>G</given-names></name><name><surname>Ma</surname><given-names>H</given-names></name><name><surname>Wang</surname><given-names>T</given-names></name><name><surname>Gao</surname><given-names>Y</given-names></name><name><surname>Qi</surname><given-names>J</given-names></name><name><surname>Chen</surname><given-names>X</given-names></name><name><surname>Zhu</surname><given-names>J</given-names></name><etal/></person-group><article-title>An unusual protector-prot&#x000e9;g&#x000e9; strategy for the biosynthesis of purine nucleoside antibiotics</article-title><source>Cell Chem Biol</source><year>2017</year><volume>24</volume><fpage>171</fpage><lpage>181</lpage><pub-id pub-id-type="doi">10.1016/j.chembiol.2016.12.012</pub-id><pub-id pub-id-type="pmid">28111097</pub-id></element-citation></ref></ref-list></back></article>